  Angiogenesis, the formation of new vessels, is one of the key mechanisms in
tumor development and an appealing target for therapy. Non-invasive,
high-resolution, high sensitivity, quantitative 3D imaging techniques are
required to correctly depict tumor heterogeneous vasculature over time.
Ultrafast Doppler was recently introduced and provides an unprecedented
combination of resolution, penetration depth and sensitivity without requiring
any contrast agents. The technique was further extended to 3D with Ultrafast
Doppler Tomography (UFD-T). In this work, UFD-T was applied to the monitoring
of tumor angiogenesis in vivo providing structural and functional information
at different stages of development. UFD-T volume renderings showed that our
murine model's vasculature stems from pre-existing vessels and sprouts to
perfuse the whole volume as the tumor grows until a critical size is reached.
Then, as the network becomes insufficient, the tumor core is no longer
irrigated because the vasculature is mainly concentrated in the periphery. In
addition to spatial distribution and growth patterns, UFD-T allowed a
quantitative analysis of vessel size and length, revealing that the
diameter-distribution of vessels remained relatively constant throughout tumor
growth. The network is dominated by small vessels at all stages of tumor
development with more than 74% of the vessels less than 200 $\mu$m in diameter.
This study also showed that cumulative vessel length is more closely related to
tumor radius than volume, indicating that the vascularization becomes
insufficient when a critical mass is reached. UFD-T was also compared with
dynamic contrast-enhanced ultrasound (DCE-US) and shown to provide
complementary information regarding the link between structure and perfusion.
In conclusion, UFD-T is capable of an in vivo quantitative assessment of the
development of tumor vasculature (vessels with blood speed >1mm/s (sensitivity
limit) assessed with a resolution limit of 80 $\mu$m) in 3D. The technique has
very interesting potential as a tool for treatment monitoring, response
assessment and treatment planning for optimal drug efficiency.
